1. Adverse events associated with infliximab therapy in a large single centre UK cohort. (13th March 2011) Authors: Sprakes, M; Hamlin, P J; Warren, L; Greer, D; Ford, A C Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-037 Epidemiology and resistance patterns of culture-positive spontaneous bacterial peritonitis in Leeds 2006–2008. (23rd September 2015) Authors: Jennings, J S R; Greer, D; Croxen, F; Davies, M; Sandoe, J Journal: Gut Issue: Volume 59(2010)Supplement 1 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P731 Effect on direct and indirect costs of switching Inflammatory Bowel Disease patients from intravenous to subcutaneous infliximab (CT-P13). (30th January 2023) Authors: Carbery, I; Broglio, G; Clark, T; Greer, D; Alakkari, A; Selinger, C P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Predictors of response and loss of response to infliximab therapy for crohn's disease: a large UK single centre experience. (13th March 2011) Authors: Sprakes, M; Ford, A C; Warren, L; Greer, D; Hamlin, P J Journal: Gut Issue: Volume 60:(2011)Supplement 1 Page Start: A218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PWE-038 Adalimumab therapy for infliximab failures in Crohn's disease. A single-centre UK experience. (23rd September 2015) Authors: Sprakes, M B; Ford, A C; Warren, L; Greer, D; Donnellan, C F; Jennings, J S R; Everett, S M; Hamlin, P J Journal: Gut Issue: Volume 59(2010)Supplement 1 Page Start: A99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial. Issue 12 (December 2018) Authors: Kasner, Scott E; Swaminathan, Balakumar; Lavados, Pablo; Sharma, Mukul; Muir, Keith; Veltkamp, Roland; Ameriso, Sebastian F; Endres, Matthias; Lutsep, Helmi; Messé, Steven R; Spence, J David; Nedeltechev, Krassen; Perera, Kanjana; Santo, Gustavo; Olavarria, Veronica; Lindgren, Arne; Bangdiwala, S... Journal: Lancet neurology Issue: Volume 17:Issue 12(2018) Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗